Investival Showcase

Medtech Leaders Spotlight: Meet Cody Simmons, CEO of DermaSensor Cody is a bioengineer and entrepreneur that has focused all of his career on bringing new health technologies to physicians and patients. Most recently he led commercial efforts for a Silicon Valley medical device screening startup and held BD and commercial strategy roles at Genentech. We kept it simple and asked Cody: How is your company making a difference? DermaSensor, Inc. was developed to address two significant challenges in healthcare: the challenges that primary care providers have in effectively managing suspicious lesions and the poor compliance and access for patients seeing dermatologists who are at risk for skin cancer.   Firstly, primary care physicians often lack the necessary tools and training to accurately identify skin lesions indicative of cancer. This leads to missed diagnoses, delayed treatment, and poorer outcomes for patients. With melanoma projected to become the second most common cancer by 2040, early detection is crucial.   Secondly, there is a shortage of dermatologists, leading to lengthy appointment wait times. Patients often have to wait months before seeing a specialist for a skin examination. This delay can result in anxiety for patients awaiting a diagnosis and can exacerbate the progression of potentially deadly skin conditions.   DermaSensor's creation represents a breakthrough approach to improving skin care in America by enabling patients with access to prompt detection and timely management of skin cancer by physicians. Cody will be presenting at the Investival Showcase USA. 🗓️ March 10-11, 2025 📍 Miami - Innovation in Paradise! 🌴 Learn more and register: https://lnkd.in/eUnJhpfJ #investivalusa #medtech #medicaldevices #medicaldevice #medicaltechnology

Biotech, medtech and healthtech companies share the same simple mission – to revolutionise healthcare. Unfortunately, simple doesn’t mean easy! Groundbreaking innovation requires more than just vision—it demands significant investment and strategic partnerships. That's where Investival Showcase comes in. 🤝 We're bridging the gap between visionary innovators and the investors and partners they need to fuel healthcare's future. Mark your calendars: 🗓️ March 10-11, 2025 📍 Miami - Sun, Sand, and Startups Learn more and register: https://lnkd.in/eUnJhpfJ Whether you're an innovator or investor, you'll find the partners you need at the Investival Showcase USA. See you there! 🌴 Informa Connect Life Sciences LSX - partnering for Life Science eXecutives BioXconomy Ford Hutman Media KKH Advisors #investivalusa #biotechnology #biotech #biopharma #medicaldevices #medtech #healthtech #healthtechnology #digitalhealth #telemedicine

🔍 Digital Health and MedTech: How to work with CVCs Join us to explore what CVCs want, and how they align with medtech and digital health M&A and BD. 🧠 Key themes:  • CVC Priorities: Balancing strategic alignment with financial returns • Synergies between CVC investments and M&A activities • Collaboration between CVCs and Business Development teams 🎙️Hear from: • Katerina Fialkovskaya, Investment Director, Philips Ventures, Philips • Murielle Thinard McLane, President & Managing Partner, Intuitive Ventures • Jonathan Machado, Managing Director, Samsung Next • Jeff Weness, Head of Digital Investments, Otsuka Precision Health, Inc. (OPH) 🗓️ March 10-11, 2025 📍 Miami - Innovation in Paradise! 🌴 Learn more and register: https://lnkd.in/eUnJhpfJ See you there! 🌞 #investivalusa #medtech #medicaldevices #healthtech #digitalhealth

Biotech Leaders Spotlight: Meet Andy Parker, CEO of Step Pharma Andy has been leading Step Pharma for the past five years. With over two decades of experience spanning pharmaceutical, biotechnology, and venture capital sectors, Andy brings a wealth of knowledge to the forefront of innovative cancer treatments. We caught up with Andy to share some insights into Step Pharma's groundbreaking work. What are your company's primary objectives for the next 1-3 years? Step Pharma will continue to expand it’s clinical activity with dencatistat, our first in class CTPS1 inhibitor, a precision oncology drug, to maximise the benefit to patients across multiple indications. In T and B cell lymphoma where we treat all comers, we expect to enter PhII in 2025. In solid tumours we exploit a synthetic lethal strategy selecting patients for loss of CTPS2, exposing a dependence on CTPS1. This represents a pan-cancer opportunity for solid tumours. The assay is validated for ovarian cancer (biomarker prevalence 20%) and is undergoing validation for several other solid tumour types including NSCLC. We expect to complete PoC studies in ovarian and one or more other solid tumour types in the next 12 months. Are there any significant milestones or launch dates we should be aware of? In essential thrombocythemia we have just started the PhIb study and expect this study to demonstrate PoC in 2025. Our clinical activities will significantly ramp up in 2025 and continue to expand through 2026 onwards necessitating an increase in personnel particularly across clinical operations and CMC. Which markets or regions will be the focus of your future expansion or growth efforts? All our studies are being executed across US, UK and EU. We will also explore options for clinical development in other geographies either directly or via regional partnerships. Consequently, we also expect to increase our Business Development capabilities as we seek partnerships to maximise the clinical development opportunities for dencatistat. Andy will be presenting at the Investival Showcase USA. 🗓️ March 10-11, 2025 📍 Miami - Sun, Sand, and Startups Discover more about Step Pharma's innovative approach to precision oncology and cancer treatment. Learn more and register: https://lnkd.in/eUnJhpfJ #investivalusa #biotechnology #biotech #biopharma #biotechleaders #CTPS1 #oncology #drugdiscovery

🌊 Ride the Wave of Healthcare Investment in 2025 Join us to explore the current state of healthcare investments and deal-making in 2025, expectations for the rest of the year, and insights into how companies can successfully navigate these dynamic waters. 🎙️Hear from: • Christian R. Schubert, VP & Head, AbbVie Ventures, AbbVie • Andrew W. Lam, PharmD, Managing Director, Head of Biotech Private Equity, Ally Bridge Group • Maha Radhakrishnan, Executive Partner, Sofinnova Investments • Evan Rachlin, Co-Founder & Managing Partner, Ascenta Capital 🧠 Key themes:  • Decoding the key factors driving investment • Exploring the role of collaborations • Comparing the US healthcare investment landscape to global trends 🗓️ March 10-11, 2025 📍 Miami - Sun, Sand, and Startups Learn more and register: https://lnkd.in/eUnJhpfJ See you there! 🌴 #investivalusa #biotechnology #biopharma #medicaldevices #digitalhealth

🎉 Black Friday Prize Draw Winners Announced! 🏆 We're thrilled to reveal the winners of our exclusive Black Friday Prize Draw, who've won a pitch and partner showcase presentation at the Investival Showcase USA, March 10-11 at the Miami Beach Convention Center. 🔬 Biotech Showcase Winner: Step Pharma 🩺 Medtech & Digital Health Showcase Winner: DermaSensor, Inc. 🌴 Join them in Miami for: • Inspiring pitches from biotech, medtech and digital health stars • Networking opportunities with industry leaders • Insights into the latest trends shaping life science innovation Learn more and secure your spot: 👉 https://lnkd.in/eUnJhpfJ #investivalusa #biotechnology #biopharma #medicaldevices #digitalhealth Adam Griffiths Andy Parker Cody Simmons

🚀 Life science innovators! Don’t miss our Black Friday Prize Draw—enter by 1st December for a chance to win 2 full-access passes 🎟️ and a company presentation slot 📊 at our Miami 🌴 life science investment event! ⬇️ Full details below. Good luck! 🍀

🏆 Win a showcase session! Are you ready to catapult your Biotech, Techbio, Healthtech, or Medtech venture into the spotlight? Enter our Black Friday Prize Draw (Nov 21 - Dec 1) for a chance to win: ✨ 2 'All-Access Pass & Showcase Presentation' packages • 1 for Biotech/Techbio • 1 for Healthtech/Medtech Why participate? • Pitch to motivated investors  • Network with industry leaders  • Accelerate your growth Don't miss this opportunity! ⏰ Time is ticking! Enter now: https://lnkd.in/exRAWgpm #investivalusa #biotech #biotechnology #techbio #biopharma #medtech #medicaldevices #digitalhealth #healthtech LSX - partnering for Life Science eXecutives LSX USA Congress Biotech Leaders Medtech Leaders Healthtech Leaders

🔓Unlock the Future of Life Science Funding! Join us for a discussion on the future of funding that you won't want to miss! We have an incredible panel of speakers: Jim MacKrell, Eli Lilly and Company • James Buxton M.D., New Enterprise Associates (NEA) • John Boyce, TigerGene LLC • Mahesh Narayanan, Neuvation Ventures • Eric Snyder, Novo Holdings Three key questions: 1. 🤖 AI & Digital Health: How are they influencing investment decisions 2. 🌱 Sustainability in Biotech: How venture capitalists are changing their evaluation criteria 3. 💼 Investor Relations: How to effectively engage with investors to foster long-term partnerships 🗓️ March 10-11, 2025 📍 Miami - Where innovation meets opportunity! Learn more and register: https://lnkd.in/eUnJhpfJ See you there! 🌴 #investivalusa #biotechnology #biopharma #medicaldevices #digitalhealth

📍 We’re at the Investival Showcase in London today! 🗣️ Isansys CEO Keith Errey is presenting on the power of real-time data and how our Patient Status Engine has: 📊 Monitored over 50,000 patients globally 📊 Predicted patient deterioration up to 47 hours earlier than manual observations This event brings together biotech, healthtech, and medtech innovators with investors and partners, creating a platform to network, pitch, and explore the future of healthcare innovation. #Investival2024 #healthtech #digitalhealth #healthcareinnovation #medtech